Adrenalone

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 561598

CAS#: 99-45-6 (free base)

Description: Adrenalone is an adrenergic agonist used as a topical vasoconstrictor and hemostatic.

Chemical Structure

img
Adrenalone
CAS# 99-45-6 (free base)
Instruction

Theoretical Analysis

MedKoo Cat#: 561598
Name: Adrenalone
CAS#: 99-45-6 (free base)
Chemical Formula: C9H11NO3
Exact Mass: 181.07
Molecular Weight: 181.190
Elemental Analysis: C, 59.66; H, 6.12; N, 7.73; O, 26.49

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 99-45-6 (free base)   62-13-5 (HCl)    

Synonym: Adrenalone; Adrenone; Chemosan; Haemodan; Kephrine; Ketogaze, Methaminoacetocatechol, Remestyp, Stryphnon, U 2134

IUPAC/Chemical Name: 1-(3,4-Dihydroxyphenyl)-2-(methylamino)ethanone

InChi Key: PZMVOUYYNKPMSI-UHFFFAOYSA-N

InChi Code: InChI=1S/C9H11NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,10-12H,5H2,1H3

SMILES Code: CNCC(C1=CC=C(O)C(O)=C1)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 181.19 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Kulinskiĭ VI, Iashunskiĭ VG, Klimova AD, Alpatova TV. [Radiation protective effect of beta-ketoanalogs of hydroxyphenyl ethanolamines]. Radiats Biol Radioecol. 1997 Nov-Dec;37(6):914-7. Russian. PubMed PMID: 9467647.

2: Lernhardt U, Strobel G, Schell H, Werle E, Weicker H. Modified syntheses of dopamine-4-sulfate, epinephrine-3-sulfate, and norepinephrine-3-sulfate: determination of the position of the sulfate group by 1H-NMR spectroscopy. Int J Sports Med. 1988 Aug;9 Suppl 2:S89-92. PubMed PMID: 3182167.

3: Kirchhoefer RD, Sullivan GM, Allgire JF. Analysis of USP epinephrine injections for potency, impurities, degradation products, and d-enantiomer by liquid chromatography, using ultraviolet and electrochemical detectors. J Assoc Off Anal Chem. 1985 Mar-Apr;68(2):163-5. PubMed PMID: 3988695.

4: Bodor N, Visor G. Improved Delivery Through Biological Membranes. XVII. A Site-Specific Chemical Delivery System as a Short-Acting Mydriatic Agent. Pharm Res. 1984 Jul;1(4):168-73. doi: 10.1023/A:1016348624897. PubMed PMID: 24277286.

5: Bodor N, Visor G. Formation of adrenaline in the iris-ciliary body from adrenalone diesters. Exp Eye Res. 1984 Jun;38(6):621-6. PubMed PMID: 6547911.

6: Kalyanaraman B, Felix CC, Sealy RC. Electron spin resonance-spin stabilization of semiquinones produced during oxidation of epinephrine and its analogues. J Biol Chem. 1984 Jan 10;259(1):354-8. PubMed PMID: 6323406.

7: Hazard R, Mouillé P. [Relations between the amine and alcohol functions of adrenaline and its hyperglycemic action. Comparative actions in the rabbit (intravenous route) of noradrenaline, ethylnoradrenaline and isoprenaline; of adrenalone, hydroxytyramine and epinine]. J Physiol (Paris). 1965 May-Jun;57(3):399-406. French. PubMed PMID: 5838236.

8: GOLDSTEIN M, MUSACCHIO JM, KENIN MC, CONTRERA JF, RICE MD. The inhibition in vivo of norepinephrine synthesis by adrenalone. Biochem Pharmacol. 1962 Aug;11:809-11. PubMed PMID: 13899911.

9: GOLDSTEIN M, CONTRERA JF. Inhibition of dopamine beta oxidase by adrenalone. Nature. 1961 Dec 16;192:1081. PubMed PMID: 13899905.

10: WEIDNER G, WEISS F. [Detection of adrenalone by means of paper chromatography even in the presence of other phenylethylamine derivatives]. Pharmazie. 1958 Jul;13(7):395-402. German. PubMed PMID: 13578644.

11: WEIDNER G. [Quantitative determination of adrenalone, especially in the presence of adrenalin]. Hoppe Seylers Z Physiol Chem. 1958;312(4-6):202-5. German. PubMed PMID: 13620204.

12: VOGELER L, REICHARDT A. [The effects of yohimbine and theophylline on subliminal doses of adrenalone]. Dtsch Med J. 1954 Oct 15;5(19-20):590-2. German. PubMed PMID: 13220295.

13: REICHELT J. [Electrophotometric determination of adrenalone]. Cesk Farm. 1953 Sep;2(9):291-3. Undetermined Language. PubMed PMID: 13116243.

14: OSINSKAIA VO. [Data on oxidation of adrenalin, noradrenalin, adrenalone and noradrenalone into fluorescent compound]. Biokhimiia. 1953 Jan-Feb;18(1):56-62. Undetermined Language. PubMed PMID: 13140375.

15: RAVINA A, MAIGNAN P. [Adrenalone: chemical and pharmacological properties; application in the treatment of asthma and asthmatiform dyspneas]. Therapie. 1953;8(3):224-30. Undetermined Language. PubMed PMID: 13136023.

16: LUDWIGS N, SCHNEIDER M. [Broncholytic effect of aralkyl adrenalin and adrenalone derivatives]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1953;218(6):432-42. Undetermined Language. PubMed PMID: 13119756.

17: VISINTIN B. [Adrenalin from adrenalone by catalytic reduction with Raney's nickel]. Rend Ist Sup Sanit. 1951;14(9):686-91. Undetermined Language. PubMed PMID: 14900491.